Mikrobielle Keratitis – Teil 2: mykotische und Akanthamöbenkeratitiden

Zusammenfassung

Pilze und Akanthamöben stellen neben Bakterien wesentliche Ursachen für die Entstehung infektiöser Hornhauterkrankungen (mikrobielle Keratitis) und möglicher nachfolgender Erblindung des betroffenen Auges dar. Aufgrund weitgehend unspezifischer Gewebereaktionen, vor allem in den Frühstadien der Entzündung, wird die Diagnose infektiöser Hornhauterkrankungen oftmals erst verspätet gestellt. Insbesondere bei Akanthamöben sind Verwechslungen mit viralen (herpetischen) Keratitiden leicht möglich. Der behandelnde Augenarzt ist daher vor hohe diagnostische Herausforderungen gestellt.

Abstract

Fungi and acanthamoeba represent potential vision threatening causes of infectious corneal inflammation (microbial keratitis). Early and correct diagnosis of the disease is often difficult due to a lack of specific initial clinical findings. Especially acanthamoeba can easily be misdiagnosed for herpetic keratitis. Therefore, ophthalmologists need to be aware of relevant clinical, diagnostic, and therapeutic characteristics of fungal and acanthamoeba keratitis which will be described and discussed in the present review.

Schlüsselwörter

mikrobielle Keratitis - Hornhautentzündung - Keratomykose - Pilzkeratitis - Akanthamöbenkeratitis

Key words

microbial keratitis - corneal inflammation - keratomycosis - fungal keratitis - acanthamoeba keratitis

• Literatur

• 1 Schmack I, Müller M, Kohnen T. Mikrobielle Keratitis, Teil 1: Allgemeine Aspekte und bakterielle Keratitiden. Augenheilkd Up2date 2018; 8: 15-34
• 2 Wong TY, Ng TP, Fong KS, Tan DT. Risk factors and clinical outcomes between fungal and bacterial keratitis: a comparative study. CLAO J 1997; 23: 275-281
• 3 Thomas PA, Kaliamurthy J. Mycotic keratitis: epidemiology, diagnosis and management. Clin Microbiol Infect 2013; 19: 201-220
• 4 Maharana P, Sharma N, Nagpal R. et al. Recent advances in diagnosis and management of mycotic keratitis. Indian J Ophthalmol 2016; 64: 346-357
• 5 Kredics L, Narendran V, Shobana CS. et al. Filamentous fungal infections of the cornea: a global overview of epidemiology and drug sensitivity. Mycoses 2015; 58: 243-260
• 6 Garg P, Roy A, Roy S. Update on fungal keratitis. Curr Opin Ophthalmol 2016; 27: 333-339
• 7 Behrens-Baumann W, Finis D, MacKenzie C. et al. Keratomycosis – therapy standards and new developments. Klin Monatsbl Augenheilkd 2015; 232: 754-764
• 8 Shukla PK, Kumar M, Keshava GBS. Mycotic keratitis: an overview of diagnosis and therapy. Mycoses 2008; 51: 183-199
• 9 Karsten E, Watson SL, Foster LJR. Diversity of microbial species implicated in keratitis: a review. Open Ophthalmol J 2012; 6: 110-124
• 10 Vemugani GK, Garg P, Gopinathan U. et al. Evaluation of agent and host factors in progression of mycotic keratitis. A histologic and microbiologic study of 167 corneal buttons. Ophthalmology 2002; 109: 1538-1546
• 11 Messmer EM. Keratitis – infectious or autoimmune?. Klin Monatsbl Augenheilkd 2016; 233: 808-812
• 12 Thomas PA. Fungal infections of the cornea. Eye 2003; 17: 852-862
• 13 Erie JC, McLaren JW, Patel SV. Confocal microscopy in ophthalmology. Am J Ophthalmol 2009; 148: 639-646
• 14 Daas L, Viestenz A, Bischoff M. et al. Konfokale Mikroskopie zur Diagnostik der mykotischen Keratitis. Ophthalmologe 2016; 113: 767-771
• 15 Kheirkhah A, Syed ZA, Satitpitakul V. et al. Sensitivity and specificity of laser-scanning in vivo confocal microscopy for filamentous fungal keratitis: role of observer experience. Am J Ophthalmol 2017; 179: 81-89
• 16 Chidambaram JD, Prajna NV, Larke NL. et al. Prospective study of the diagnostic accuracy of the in vivo laser scanning confocal microscopy for severe microbial keratitis. Ophthalmology 2016; 123: 2285-2293
• 17 Austin A, Lietman T, Rose-Nussbaumer J. Update on the management of infectious keratitis. Ophthalmology 2017;
• 18 Sharma S, Das S, Virdi A. et al. Re-appraisal of topical 1 % voriconazol and 5 % natamycin in the treatment of fungal keratitis in a randomized trial. Br J Ophthalmol 2015; 99: 1190-1195
• 19 Matoba AY, Barret R, Lehmann AE. Cure rate of fungal keratitis with antibacterial therapy. Cornea 2017; 36: 578-580
• 20 Lakhundi S, Siddiqui R, Khan NA. Pathogenesis of microbial keratitis. Microb Pathog 2017; 104: 97-109
• 21 Ong SH, Corbett MC. Corneal infections in the 21st century. Postgrad Med J 2015; 91: 565-571
• 22 Lorenzo-Morales J, Kahn NA, Walochnik J. An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment. Parasite 2015; 22: 10
• 23 Pleyer U. Entzündliche Augenerkrankungen. Berlin, Heidelberg: Springer; 2014
• 24 Maycock NJR, Jayaswal R. Update on acanthamoeba keratitis: diagnosis, treatment, and outcomes. Cornea 2016; 35: 713-720
• 25 Meltendorf C, Duncker G. Acanthamoeba keratitis. Klin Monatsbl Augenheilkd 2011; 228: R29-R43
• 26 Dart JKG, Saw VJP, Kilvington S. Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol 2009; 148: 487-499
• 27 Clarke DW, Niederkorn JY. The immunobiology of Acanthamoeba keratitis. Microbes Infect 2006; 8: 1400-1405
• 28 Behera HS, Satpathy G. Characterization and expression analysis of trophozoite and cyst proteins of Acanthamoeba spp. isolated from Acanthamoeba keratitis (AK) patient. Mol Biochem Parasitol 2016; 205: 29-34
• 29 Clarke DW, Niederkorn JY. The pathophysiology of Acanthamoeba keratitis. Trends Parasitol 2006; 22: 175-180
• 30 Yanoff M, Fine BS. Ocular Pathology. 5. Aufl.. St. Louis, Missouri: Mosby; 2002
• 31 Padhi TR, Das S, Sharma S. et al. Ocular parasitoses: a comprehensive review. Surv Ophthalmol 2017; 62: 161-189
• 32 Illingworth CD, Cook SD, Karabatsas CH. et al. Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol 1995; 79: 1078-1082